MaxCyte, Inc.

MXCT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$41-$38-$24-$19
Dep. & Amort.$4$5$3$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$14$0$8
Change in WC-$1$4-$3-$2
Other Non-Cash$10-$6$9$1
Operating Cash Flow-$28-$22-$15-$11
Investing Activities
PP&E Inv.-$2-$4-$18-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$151-$255-$291-$269
Inv. Sales/Matur.$159$314$285$78
Other Inv. Act.$0$0$0$0
Investing Cash Flow$7$55-$25-$195
Financing Activities
Debt Repay.$0$0$0-$5
Stock Issued$2$0$3$236
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$2$0$4
Financing Cash Flow$2$2$3$235
Forex Effect$0$0$0$0
Net Chg. in Cash-$19$35-$37$29
Supplemental Information
Beg. Cash$47$11$48$19
End Cash$28$47$11$48
Free Cash Flow-$29-$25-$33-$15